Histogenics Corporation
Biotechnology Research
Waltham, MA 1,674 followers
Histogenics Corporation was acquired by Ocugen, Inc. on September 27, 2019. For more information, visit www.ocugen.com.
About us
Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019. Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient’s own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA). Read our community guidelines: https://goo.gl/Qtusgh
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Founded
- 2000
- Specialties
- Regenerative Medicine, Tissue Engineering, Musculoskeletal and Orthopaedics, and Cartilage Regeneration and Repair
Locations
-
Primary
Get directions
Waltham, MA 02451, US